Adiponectin-Consideration for Its Role in Skeletal Muscle Health

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2019 Apr 3

PMID 30934678

Citations 55

Authors

Matthew P Krause

Kevin J Milne

Thomas J Hawke

Affiliations

Soon will be listed here.

Abstract

Adiponectin regulates metabolism through blood glucose control and fatty acid oxidation, partly mediated by downstream effects of adiponectin signaling in skeletal muscle. More recently, skeletal muscle has been identified as a source of adiponectin expression, fueling interest in the role of adiponectin as both a circulating adipokine and a locally expressed paracrine/autocrine factor. In addition to being metabolically responsive, skeletal muscle functional capacity, calcium handling, growth and maintenance, regenerative capacity, and susceptibility to chronic inflammation are all strongly influenced by adiponectin stimulation. Furthermore, physical exercise has clear links to adiponectin expression and circulating concentrations in healthy and diseased populations. Greater physical activity is generally related to higher adiponectin expression while lower adiponectin levels are found in inactive obese, pre-diabetic, and diabetic populations. Exercise training typically restores plasma adiponectin and is associated with improved insulin sensitivity. Thus, the role of adiponectin signaling in skeletal muscle has expanded beyond that of a metabolic regulator to include several aspects of skeletal muscle function and maintenance critical to muscle health, many of which are responsive to, and mediated by, physical exercise.

Citing Articles

The Influence of Body Composition, Lifestyle, and Dietary Components on Adiponectin and Resistin Levels and AR Index in Obese Individuals.

Polak-Szczybylo E, Tabarkiewicz J Int J Mol Sci. 2025; 26(1.

PMID: 39796247 PMC: 11720087. DOI: 10.3390/ijms26010393.

Visceral Fat Affects Heart Rate Recovery but Not the Heart Rate Response Post-Single Bout of Vigorous Exercise: A Cross-Sectional Study in Non-Obese and Healthy Participants.

Amato A, Petrigna L, Sortino M, Musumeci G Sports (Basel). 2024; 12(12).

PMID: 39728863 PMC: 11679373. DOI: 10.3390/sports12120323.

Limitations in metabolic plasticity after traumatic injury are only moderately exacerbated by physical activity restriction.

Bruzina A, Raymond-Pope C, Murray K, Lillquist T, Castelli K, Bijwadia S NPJ Metab Health Dis. 2024; 2.

PMID: 39421399 PMC: 11486518. DOI: 10.1038/s44324-024-00006-5.

Injection of Adipose-Derived Mesenchymal Stem/Stromal Cells Suppresses Muscle Atrophy Markers and Adipogenic Markers in a Rat Fatty Muscle Degeneration Model.

Ngeun S, Shimizu M, Kaneda M Curr Issues Mol Biol. 2024; 46(8):7877-7894.

PMID: 39194684 PMC: 11352917. DOI: 10.3390/cimb46080467.

Sarcopenic obesity in patients awaiting liver transplant: Unique challenges for nutritional recommendations.

Herscovici D, Cooper K, Colletta A, Rightmyer M, Shingina A, Feld L World J Transplant. 2024; 14(2):90202.

PMID: 38947969 PMC: 11212592. DOI: 10.5500/wjt.v14.i2.90202.

References

Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J . Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999; 257(1):79-83. DOI: 10.1006/bbrc.1999.0255. View

Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y . Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 1999; 100(25):2473-6. DOI: 10.1161/01.cir.100.25.2473. View

Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y . Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000; 20(6):1595-9. DOI: 10.1161/01.atv.20.6.1595. View

Gurlek A, Bayraktar M, Kirazli S . Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels. Diabetes Care. 2000; 23(1):88-92. DOI: 10.2337/diacare.23.1.88. View

Berchtold M, Brinkmeier H, Muntener M . Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease. Physiol Rev. 2000; 80(3):1215-65. DOI: 10.1152/physrev.2000.80.3.1215. View

Fruebis J, Tsao T, Javorschi S, Erickson M, Yen F, Bihain B . Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A. 2001; 98(4):2005-10. PMC: 29372. DOI: 10.1073/pnas.98.4.2005. View

Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K . The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001; 7(8):941-6. DOI: 10.1038/90984. View

Wang Y, Xu A, Knight C, Xu L, Cooper G . Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity. J Biol Chem. 2002; 277(22):19521-9. DOI: 10.1074/jbc.M200601200. View

Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S . Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002; 8(11):1288-95. DOI: 10.1038/nm788. View

10.

Spranger J, Kroke A, Mohlig M, Bergmann M, Ristow M, Boeing H . Adiponectin and protection against type 2 diabetes mellitus. Lancet. 2003; 361(9353):226-8. DOI: 10.1016/S0140-6736(03)12255-6. View

11.

Lan H, Rabaglia M, Stoehr J, Nadler S, Schueler K, Zou F . Gene expression profiles of nondiabetic and diabetic obese mice suggest a role of hepatic lipogenic capacity in diabetes susceptibility. Diabetes. 2003; 52(3):688-700. DOI: 10.2337/diabetes.52.3.688. View

12.

Cnop M, Havel P, Utzschneider K, Carr D, Sinha M, Boyko E . Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003; 46(4):459-69. DOI: 10.1007/s00125-003-1074-z. View

13.

Lakka T, Laaksonen D, Lakka H, Mannikko N, Niskanen L, Rauramaa R . Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome. Med Sci Sports Exerc. 2003; 35(8):1279-86. DOI: 10.1249/01.MSS.0000079076.74931.9A. View

14.

Bajaj M, Suraamornkul S, Piper P, Hardies L, Glass L, Cersosimo E . Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab. 2004; 89(1):200-6. DOI: 10.1210/jc.2003-031315. View

15.

Rennie M, Wackerhage H, Spangenburg E, Booth F . Control of the size of the human muscle mass. Annu Rev Physiol. 2004; 66:799-828. DOI: 10.1146/annurev.physiol.66.052102.134444. View

16.

Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe D . Adiponectin and breast cancer risk. J Clin Endocrinol Metab. 2004; 89(3):1102-7. DOI: 10.1210/jc.2003-031804. View

17.

Pischon T, Girman C, Hotamisligil G, Rifai N, Hu F, Rimm E . Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004; 291(14):1730-7. DOI: 10.1001/jama.291.14.1730. View

18.

Bottner A, Kratzsch J, Muller G, Kapellen T, Bluher S, Keller E . Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab. 2004; 89(8):4053-61. DOI: 10.1210/jc.2004-0303. View

19.

Delaigle A, Jonas J, Bauche I, Cornu O, Brichard S . Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies. Endocrinology. 2004; 145(12):5589-97. DOI: 10.1210/en.2004-0503. View

20.

Bajaj M, Suraamornkul S, Kashyap S, Cusi K, Mandarino L, DeFronzo R . Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes. J Clin Endocrinol Metab. 2004; 89(9):4649-55. DOI: 10.1210/jc.2004-0224. View